We are live on ! Find out more
KRSA icon

Korsana Biosciences

36 hedge funds and large institutions have $11.5M invested in Korsana Biosciences in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.99% less ownership

Funds ownership: 53.11% → 48.12% (-5%)

22% less funds holding

Funds holding: 46 → 36 (-10)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

88% less capital inflows, than outflows

Capital inflows: $312K | Capital outflows: $2.58M

Holders
36
Holders Change
-10
Holders Change %
-21.74%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
10
Closed
13
Calls
$254​K
Puts
–
Net Calls
+$254​K
Net Calls Change
-⁠$144​K

KRSA Hedge Fund Activity: Q2 2022 in Review

36 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences (KRSA) for Q2 2022, worth a combined $11.5M — down 55% from $25.6M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of KRSA and 4 opened new positions — a net loss of 9 holders — while 10 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $110K. The largest seller was Pura Vida Investments, exiting entirely with an estimated $862K sold.

  • 36 institutional investors held Korsana Biosciences (KRSA) as of Q2 2022, down from 46 in Q1 2022.
  • Funds reported $11.5M of Korsana Biosciences stock for Q2 2022, down 55% quarter-over-quarter.
  • 4 funds opened new Korsana Biosciences positions in Q2 2022 and 13 closed out, a net change of -9 holders.
  • The largest Korsana Biosciences buyer in Q2 2022 was Renaissance Technologies, an estimated $110K added.
  • The largest Korsana Biosciences seller in Q2 2022 was Pura Vida Investments, an estimated $862K sold.

Based on aggregated 13F filings for Q2 2022.